Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Therapeutic Nuclear Medicines market report explains the definition, types, applications, major countries, and major players of the Therapeutic Nuclear Medicines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
China Isotope & Radiation
Jubilant DraxImage
Curium Pharmaceuticals
Q BioMed
Lantheus
International Isotopes
Dongcheng
Bayer
Novartis AG
Acrotech Biopharma, Progenics Pharmaceuticals
By Type:
Radium-223
Lutetium-177
Iodine-131
Other
By End-User:
Thyroid
Bone Metastasis
Lymphoma
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Therapeutic Nuclear Medicines Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Therapeutic Nuclear Medicines Outlook to 2028- Original Forecasts
-
2.2 Therapeutic Nuclear Medicines Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Therapeutic Nuclear Medicines Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Therapeutic Nuclear Medicines Market- Recent Developments
-
6.1 Therapeutic Nuclear Medicines Market News and Developments
-
6.2 Therapeutic Nuclear Medicines Market Deals Landscape
7 Therapeutic Nuclear Medicines Raw Materials and Cost Structure Analysis
-
7.1 Therapeutic Nuclear Medicines Key Raw Materials
-
7.2 Therapeutic Nuclear Medicines Price Trend of Key Raw Materials
-
7.3 Therapeutic Nuclear Medicines Key Suppliers of Raw Materials
-
7.4 Therapeutic Nuclear Medicines Market Concentration Rate of Raw Materials
-
7.5 Therapeutic Nuclear Medicines Cost Structure Analysis
-
7.5.1 Therapeutic Nuclear Medicines Raw Materials Analysis
-
7.5.2 Therapeutic Nuclear Medicines Labor Cost Analysis
-
7.5.3 Therapeutic Nuclear Medicines Manufacturing Expenses Analysis
8 Global Therapeutic Nuclear Medicines Import and Export Analysis (Top 10 Countries)
-
8.1 Global Therapeutic Nuclear Medicines Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Therapeutic Nuclear Medicines Export by Region (Top 10 Countries) (2017-2028)
9 Global Therapeutic Nuclear Medicines Market Outlook by Types and Applications to 2022
-
9.1 Global Therapeutic Nuclear Medicines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Radium-223 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lutetium-177 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Iodine-131 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Therapeutic Nuclear Medicines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Thyroid Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Bone Metastasis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Therapeutic Nuclear Medicines Market Analysis and Outlook till 2022
-
10.1 Global Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.2.2 Canada Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.2.3 Mexico Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.2 UK Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.3 Spain Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.4 Belgium Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.5 France Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.6 Italy Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.7 Denmark Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.8 Finland Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.9 Norway Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.10 Sweden Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.11 Poland Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.12 Russia Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.3.13 Turkey Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4.2 Japan Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4.3 India Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4.4 South Korea Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4.5 Pakistan Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4.6 Bangladesh Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4.7 Indonesia Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4.8 Thailand Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4.9 Singapore Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4.10 Malaysia Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4.11 Philippines Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.4.12 Vietnam Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.5.2 Colombia Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.5.3 Chile Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.5.4 Argentina Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.5.5 Venezuela Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.5.6 Peru Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.5.7 Puerto Rico Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.5.8 Ecuador Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.6.2 Kuwait Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.6.3 Oman Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.6.4 Qatar Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.6.5 Saudi Arabia Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.6.6 United Arab Emirates Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.7.2 South Africa Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.7.3 Egypt Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.7.4 Algeria Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Therapeutic Nuclear Medicines Consumption (2017-2022)
-
10.8.2 New Zealand Therapeutic Nuclear Medicines Consumption (2017-2022)
11 Global Therapeutic Nuclear Medicines Competitive Analysis
-
11.1 China Isotope & Radiation
-
11.1.1 China Isotope & Radiation Company Details
-
11.1.2 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 China Isotope & Radiation Therapeutic Nuclear Medicines Main Business and Markets Served
-
11.1.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Jubilant DraxImage
-
11.2.1 Jubilant DraxImage Company Details
-
11.2.2 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Jubilant DraxImage Therapeutic Nuclear Medicines Main Business and Markets Served
-
11.2.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Curium Pharmaceuticals
-
11.3.1 Curium Pharmaceuticals Company Details
-
11.3.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Main Business and Markets Served
-
11.3.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Q BioMed
-
11.4.1 Q BioMed Company Details
-
11.4.2 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Q BioMed Therapeutic Nuclear Medicines Main Business and Markets Served
-
11.4.4 Q BioMed Therapeutic Nuclear Medicines Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Lantheus
-
11.5.1 Lantheus Company Details
-
11.5.2 Lantheus Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Lantheus Therapeutic Nuclear Medicines Main Business and Markets Served
-
11.5.4 Lantheus Therapeutic Nuclear Medicines Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 International Isotopes
-
11.6.1 International Isotopes Company Details
-
11.6.2 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 International Isotopes Therapeutic Nuclear Medicines Main Business and Markets Served
-
11.6.4 International Isotopes Therapeutic Nuclear Medicines Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Dongcheng
-
11.7.1 Dongcheng Company Details
-
11.7.2 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Dongcheng Therapeutic Nuclear Medicines Main Business and Markets Served
-
11.7.4 Dongcheng Therapeutic Nuclear Medicines Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Bayer
-
11.8.1 Bayer Company Details
-
11.8.2 Bayer Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Bayer Therapeutic Nuclear Medicines Main Business and Markets Served
-
11.8.4 Bayer Therapeutic Nuclear Medicines Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Novartis AG
-
11.9.1 Novartis AG Company Details
-
11.9.2 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Novartis AG Therapeutic Nuclear Medicines Main Business and Markets Served
-
11.9.4 Novartis AG Therapeutic Nuclear Medicines Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Acrotech Biopharma, Progenics Pharmaceuticals
-
11.10.1 Acrotech Biopharma, Progenics Pharmaceuticals Company Details
-
11.10.2 Acrotech Biopharma, Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Acrotech Biopharma, Progenics Pharmaceuticals Therapeutic Nuclear Medicines Main Business and Markets Served
-
11.10.4 Acrotech Biopharma, Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Therapeutic Nuclear Medicines Market Outlook by Types and Applications to 2028
-
12.1 Global Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Iodine-131 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Thyroid Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Bone Metastasis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Therapeutic Nuclear Medicines Market Analysis and Outlook to 2028
-
13.1 Global Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.2.2 Canada Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.2.3 Mexico Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.2 UK Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.3 Spain Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.4 Belgium Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.5 France Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.6 Italy Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.7 Denmark Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.8 Finland Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.9 Norway Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.10 Sweden Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.11 Poland Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.12 Russia Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.13 Turkey Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.2 Japan Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.3 India Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.4 South Korea Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.8 Thailand Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.9 Singapore Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.11 Philippines Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.2 Colombia Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.3 Chile Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.4 Argentina Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.6 Peru Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6.3 Oman Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6.4 Qatar Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.7.2 South Africa Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.7.3 Egypt Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.7.4 Algeria Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Therapeutic Nuclear Medicines
-
Figure of Therapeutic Nuclear Medicines Picture
-
Table Global Therapeutic Nuclear Medicines Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Therapeutic Nuclear Medicines Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Radium-223 Consumption and Growth Rate (2017-2022)
-
Figure Global Lutetium-177 Consumption and Growth Rate (2017-2022)
-
Figure Global Iodine-131 Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Thyroid Consumption and Growth Rate (2017-2022)
-
Figure Global Bone Metastasis Consumption and Growth Rate (2017-2022)
-
Figure Global Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Nuclear Medicines Consumption by Country (2017-2022)
-
Table North America Therapeutic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure United States Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Canada Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Mexico Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table Europe Therapeutic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure Germany Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure UK Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Spain Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Belgium Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure France Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Italy Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Denmark Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Finland Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Norway Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Sweden Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Poland Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Russia Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Turkey Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table APAC Therapeutic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure China Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Japan Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure India Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Thailand Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Singapore Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Philippines Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table South America Therapeutic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure Brazil Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Colombia Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Chile Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Argentina Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Peru Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table GCC Therapeutic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure Bahrain Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Oman Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Qatar Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table Africa Therapeutic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure Nigeria Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure South Africa Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Egypt Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Algeria Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table Oceania Therapeutic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure Australia Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table China Isotope & Radiation Company Details
-
Table China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Isotope & Radiation Therapeutic Nuclear Medicines Main Business and Markets Served
-
Table China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio
-
Table Jubilant DraxImage Company Details
-
Table Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jubilant DraxImage Therapeutic Nuclear Medicines Main Business and Markets Served
-
Table Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio
-
Table Curium Pharmaceuticals Company Details
-
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Main Business and Markets Served
-
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
-
Table Q BioMed Company Details
-
Table Q BioMed Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Q BioMed Therapeutic Nuclear Medicines Main Business and Markets Served
-
Table Q BioMed Therapeutic Nuclear Medicines Product Portfolio
-
Table Lantheus Company Details
-
Table Lantheus Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Therapeutic Nuclear Medicines Main Business and Markets Served
-
Table Lantheus Therapeutic Nuclear Medicines Product Portfolio
-
Table International Isotopes Company Details
-
Table International Isotopes Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table International Isotopes Therapeutic Nuclear Medicines Main Business and Markets Served
-
Table International Isotopes Therapeutic Nuclear Medicines Product Portfolio
-
Table Dongcheng Company Details
-
Table Dongcheng Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dongcheng Therapeutic Nuclear Medicines Main Business and Markets Served
-
Table Dongcheng Therapeutic Nuclear Medicines Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Therapeutic Nuclear Medicines Main Business and Markets Served
-
Table Bayer Therapeutic Nuclear Medicines Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Therapeutic Nuclear Medicines Main Business and Markets Served
-
Table Novartis AG Therapeutic Nuclear Medicines Product Portfolio
-
Table Acrotech Biopharma, Progenics Pharmaceuticals Company Details
-
Table Acrotech Biopharma, Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acrotech Biopharma, Progenics Pharmaceuticals Therapeutic Nuclear Medicines Main Business and Markets Served
-
Table Acrotech Biopharma, Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
-
Figure Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Iodine-131 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thyroid Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone Metastasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Table North America Therapeutic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure United States Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Therapeutic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure Germany Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Therapeutic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure China Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Therapeutic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure Brazil Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Therapeutic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Therapeutic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Therapeutic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure Australia Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
